Mandatory notification of intra group transfer of shares by primary insider’s related party
Nykode Therapeutics ASA (NYKD) · publisert 2022-10-24 15:58 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Cipriano AS 2 Details of the person discharging managerial responsibilities a) Name Einar J. Greve | – | other | 1 625 000 | 0 NOK | 2022-10-24 | NO0010714785 | Outside of trading venue | rules · til gjennomgang |
Vedlegg
- Attachment Cipriano 221024.pdf (tekst hentet ut)
Meldingstekst
Oslo, Norway, October 24, 2022 - Cipriano AS and Cipriano Invest AS, a 100% owned subsidiary of Cipriano AS, have merged. As a result, 1,625,000 shares in Nykode Therapeutics ASA have been transferred from Cipriano Invest AS to Cipriano AS. Cipriano AS is 100% owned by primary insider Einar J. Greve, Deputy Board Member of Nykode Therapeutics ASA.
Please see further details in attached document.